Top Markets
Coin of the day
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Kedudukan dalam Saham #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Harga Saham
$0.617
Disegerakkan terakhir: 2024-10-14
Modal Pasaran
$6.13M
Perubahan (1 hari)
0.49%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Kineta, Inc. (KA)

Kategori

Nisbah P/B bagi Kineta, Inc. (KA)
Nisbah P/B pada August 2026 TTM: -0.58
Menurut laporan kewangan dan harga saham terkini Kineta, Inc., nisbah P/B semasa (TTM) ialah -0.58. Pada akhir 2023, nisbah P/B syarikat ialah 13.88.
Sejarah nisbah P/B untuk Kineta, Inc. dari 2015 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
2026 (TTM) -0.58 -6.79%
2024 -0.62 -104.47%
2023 13.88 96.37%
2022 7.07 -463.47%
2021 -1.95 36.18%
2020 -1.43 -198.50%
2019 1.45 71.37%
2018 0.85 -49.33%
2017 1.67 -23.75%
2016 2.19 -92.84%
2015 30.60 0.00%
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
6.3419 -1,197.40%
US
6.2413 -1,180.00%
NL
- -
CH
- -
KR
3.4612 -698.93%
BE